EDAP TMS S.A. (EDAP)
USD 2.16
(-12.2%)
USD 2.16
(-12.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 24.41 Million EUR | -1.17% |
| 2022 | 24.19 Million EUR | 31.32% |
| 2021 | 18.42 Million EUR | 0.24% |
| 2020 | 18.37 Million EUR | -12.49% |
| 2019 | 21 Million EUR | 24.15% |
| 2018 | 16.91 Million EUR | 14.24% |
| 2017 | 14.8 Million EUR | -9.77% |
| 2016 | 16.41 Million EUR | 19.05% |
| 2015 | 13.78 Million EUR | 23.07% |
| 2014 | 11.2 Million EUR | 20.21% |
| 2013 | 9.31 Million EUR | -10.69% |
| 2012 | 10.43 Million EUR | 17.79% |
| 2011 | 8.85 Million EUR | -6.32% |
| 2010 | 9.45 Million EUR | -11.4% |
| 2009 | 10.67 Million EUR | 17.3% |
| 2008 | 9.09 Million EUR | -1.04% |
| 2007 | 9.19 Million EUR | 10.51% |
| 2006 | 8.31 Million EUR | -2.02% |
| 2005 | 8.49 Million EUR | 0.13% |
| 2004 | 8.48 Million EUR | 57.94% |
| 2003 | 5.36 Million EUR | -36.57% |
| 2002 | 8.46 Million EUR | -3.7% |
| 2001 | 8.79 Million EUR | -32.88% |
| 2000 | 13.09 Million EUR | 56.12% |
| 1999 | 8.38 Million EUR | -27.66% |
| 1998 | 11.59 Million EUR | -29.91% |
| 1997 | 16.54 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 5.94 Million EUR | -7.84% |
| 2024 Q1 | 6.42 Million EUR | -23.01% |
| 2023 Q4 | 8.34 Million EUR | 100.39% |
| 2023 Q1 | 6.03 Million USD | -16.44% |
| 2023 Q3 | 4.16 Million EUR | -26.4% |
| 2023 FY | 23.91 Million EUR | -1.17% |
| 2023 Q2 | 5.65 Million EUR | -6.22% |
| 2022 Q1 | 5.75 Million EUR | -7.29% |
| 2022 FY | 24.19 Million EUR | 31.32% |
| 2022 Q4 | 7.21 Million EUR | 43.87% |
| 2022 Q3 | 5.01 Million EUR | -19.09% |
| 2022 Q2 | 6.2 Million EUR | 7.71% |
| 2021 FY | 18.42 Million EUR | 0.24% |
| 2021 Q4 | 6.21 Million EUR | 71.31% |
| 2021 Q3 | 3.62 Million EUR | -14.0% |
| 2021 Q2 | 4.21 Million EUR | -3.55% |
| 2021 Q1 | 4.37 Million EUR | -37.82% |
| 2020 Q3 | 3.96 Million EUR | -8.35% |
| 2020 Q1 | 3.06 Million EUR | -40.42% |
| 2020 Q2 | 4.32 Million EUR | 41.25% |
| 2020 FY | 18.37 Million EUR | -12.49% |
| 2020 Q4 | 7.02 Million EUR | 77.3% |
| 2019 Q1 | 4.86 Million EUR | -18.66% |
| 2019 Q2 | 6.33 Million EUR | 30.13% |
| 2019 Q4 | 5.13 Million EUR | -67.6% |
| 2019 FY | 21 Million EUR | 24.15% |
| 2019 Q3 | 15.86 Million EUR | 150.52% |
| 2018 Q4 | 5.98 Million EUR | 77.3% |
| 2018 FY | 16.91 Million EUR | 14.24% |
| 2018 Q3 | 3.37 Million EUR | -4.96% |
| 2018 Q2 | 3.55 Million EUR | -11.49% |
| 2018 Q1 | 4.01 Million EUR | -9.5% |
| 2017 Q2 | 4.01 Million EUR | 13.06% |
| 2017 Q4 | 4.43 Million EUR | 57.83% |
| 2017 FY | 14.8 Million EUR | -9.77% |
| 2017 Q1 | 3.55 Million EUR | -31.72% |
| 2017 Q3 | 2.8 Million EUR | -30.08% |
| 2016 Q4 | 5.2 Million EUR | 50.56% |
| 2016 FY | 16.41 Million EUR | 19.05% |
| 2016 Q2 | 3.46 Million EUR | -19.36% |
| 2016 Q1 | 4.29 Million EUR | -18.97% |
| 2016 Q3 | 3.45 Million EUR | -0.17% |
| 2015 Q2 | 3.33 Million EUR | 29.15% |
| 2015 Q3 | 2.57 Million EUR | -22.69% |
| 2015 Q4 | 5.29 Million EUR | 105.63% |
| 2015 FY | 13.78 Million EUR | 23.07% |
| 2015 Q1 | 2.58 Million EUR | 6.22% |
| 2014 Q2 | 1.8 Million EUR | -49.4% |
| 2014 Q3 | 3.4 Million EUR | 88.96% |
| 2014 Q4 | 2.42 Million EUR | -28.71% |
| 2014 Q1 | 3.56 Million EUR | 9.5% |
| 2014 FY | 11.2 Million EUR | 20.21% |
| 2013 Q3 | 2.24 Million EUR | 37.65% |
| 2013 FY | 9.31 Million EUR | -10.69% |
| 2013 Q1 | 2.19 Million EUR | -43.51% |
| 2013 Q4 | 3.25 Million EUR | 45.2% |
| 2013 Q2 | 1.62 Million EUR | -25.9% |
| 2012 Q4 | 3.88 Million EUR | 73.0% |
| 2012 FY | 10.43 Million EUR | 17.79% |
| 2012 Q3 | 2.24 Million EUR | -6.02% |
| 2012 Q1 | 1.9 Million EUR | -32.05% |
| 2012 Q2 | 2.39 Million EUR | 25.76% |
| 2011 Q4 | 2.79 Million EUR | 9.38% |
| 2011 Q2 | 1.52 Million EUR | -22.87% |
| 2011 Q1 | 1.97 Million EUR | -34.7% |
| 2011 FY | 8.85 Million EUR | -6.32% |
| 2011 Q3 | 2.55 Million EUR | 67.91% |
| 2010 FY | 9.45 Million EUR | -11.4% |
| 2010 Q4 | 3.02 Million EUR | 35.88% |
| 2010 Q1 | 1.71 Million EUR | -53.31% |
| 2010 Q2 | 2.48 Million EUR | 44.99% |
| 2010 Q3 | 2.22 Million EUR | -10.49% |
| 2009 Q3 | 1.69 Million EUR | -46.52% |
| 2009 Q1 | 2.12 Million EUR | -35.25% |
| 2009 FY | 10.67 Million EUR | 17.3% |
| 2009 Q4 | 3.67 Million EUR | 116.56% |
| 2009 Q2 | 3.17 Million EUR | 49.18% |
| 2008 Q1 | 1.89 Million EUR | -37.51% |
| 2008 FY | 9.09 Million EUR | -1.04% |
| 2008 Q4 | 3.28 Million EUR | 65.66% |
| 2008 Q3 | 1.98 Million EUR | 3.47% |
| 2008 Q2 | 1.91 Million EUR | 1.26% |
| 2007 Q1 | 4.6 Million EUR | 145.85% |
| 2007 Q2 | 5.95 Million EUR | 29.22% |
| 2007 Q3 | 1.82 Million EUR | -69.3% |
| 2007 FY | 9.19 Million EUR | 10.51% |
| 2007 Q4 | 3.02 Million EUR | 65.78% |
| 2006 Q1 | 2.27 Million EUR | -3.77% |
| 2006 Q4 | 1.87 Million EUR | -8.39% |
| 2006 Q3 | 2.04 Million EUR | -4.85% |
| 2006 Q2 | 2.14 Million EUR | -5.66% |
| 2006 FY | 8.31 Million EUR | -2.02% |
| 2005 Q2 | 2.08 Million EUR | 0.05% |
| 2005 Q1 | 2.08 Million EUR | -6.41% |
| 2005 FY | 8.49 Million EUR | 0.13% |
| 2005 Q4 | 2.36 Million EUR | 26.79% |
| 2005 Q3 | 1.86 Million EUR | -10.41% |
| 2004 Q1 | 2.42 Million EUR | 157.79% |
| 2004 Q4 | 2.22 Million EUR | 0.19% |
| 2004 Q2 | 2.02 Million EUR | -16.45% |
| 2004 FY | 8.48 Million EUR | 57.94% |
| 2004 Q3 | 2.22 Million EUR | 9.69% |
| 2003 Q3 | 1.36 Million EUR | -15.37% |
| 2003 Q1 | 1.56 Million EUR | -49.01% |
| 2003 Q2 | 1.61 Million EUR | 3.06% |
| 2003 Q4 | 940.15 Thousand EUR | -31.2% |
| 2003 FY | 5.36 Million EUR | -36.57% |
| 2002 Q4 | 3.07 Million EUR | 96.15% |
| 2002 FY | 8.46 Million EUR | -3.7% |
| 2002 Q3 | 1.56 Million EUR | -65.07% |
| 2002 Q2 | 4.48 Million EUR | -11.09% |
| 2002 Q1 | 5.04 Million EUR | -29.12% |
| 2001 Q3 | 5.21 Million EUR | -18.2% |
| 2001 Q2 | 6.38 Million EUR | 7.76% |
| 2001 Q1 | 5.92 Million EUR | -14.45% |
| 2001 FY | 8.79 Million EUR | -32.88% |
| 2001 Q4 | 7.11 Million EUR | 36.36% |
| 2000 Q3 | 7.93 Million EUR | 33.65% |
| 2000 Q1 | 5.55 Million EUR | 29.39% |
| 2000 Q2 | 5.93 Million EUR | 6.91% |
| 2000 FY | 13.09 Million EUR | 56.12% |
| 2000 Q4 | 6.92 Million EUR | -12.78% |
| 1999 Q2 | 4.82 Million EUR | -18.77% |
| 1999 FY | 8.38 Million EUR | -27.66% |
| 1999 Q1 | 5.94 Million EUR | -15.91% |
| 1999 Q4 | 4.29 Million EUR | 1.98% |
| 1999 Q3 | 4.2 Million EUR | -12.85% |
| 1998 Q3 | 3.73 Million EUR | -48.11% |
| 1998 Q1 | 6.12 Million EUR | -39.8% |
| 1998 FY | 11.59 Million EUR | -29.91% |
| 1998 Q4 | 7.07 Million EUR | 89.37% |
| 1998 Q2 | 7.19 Million EUR | 17.41% |
| 1997 Q3 | 8.2 Million EUR | 81.28% |
| 1997 Q4 | 10.18 Million EUR | 24.04% |
| 1997 FY | 16.54 Million EUR | 0.0% |
| 1997 Q1 | 4.56 Million EUR | 0.0% |
| 1997 Q2 | 4.52 Million EUR | -0.91% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 310.2 Million USD | 92.131% |
| Nemaura Medical Inc. | -1.47 Million USD | 1753.423% |
| NeuroPace, Inc. | 48.12 Million USD | 49.273% |
| LENSAR, Inc. | 21.1 Million USD | -15.654% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -53.47% |
| Apyx Medical Corporation | 14.12 Million USD | -72.858% |
| Cutera, Inc. | 41.49 Million USD | 41.17% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -32.23% |
| BioSig Technologies, Inc. | 18 Thousand USD | -135516.667% |
| Talis Biomedical Corporation | 371 Thousand USD | -6479.784% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 97.252% |
| Cerus Corporation | 86.4 Million USD | 71.747% |
| Axonics, Inc. | 274.55 Million USD | 91.109% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 83.933% |
| Outset Medical, Inc. | 29 Million USD | 15.824% |
| IRIDEX Corporation | 21.8 Million USD | -11.941% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 65.642% |
| TELA Bio, Inc. | 40.11 Million USD | 39.143% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -8405.575% |
| RxSight, Inc. | 53.76 Million USD | 54.597% |
| INVO Bioscience, Inc. | 1.08 Million USD | -2147.504% |
| electroCore, Inc. | 13.22 Million USD | -84.568% |
| Telesis Bio, Inc. | 16.95 Million USD | -44.018% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 78.356% |
| Quipt Home Medical Corp. | 163.84 Million USD | 85.101% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 6112.562% |
| Pulmonx Corporation | 50.75 Million USD | 51.901% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 503.488% |
| Dynatronics Corporation | 7.63 Million USD | -219.726% |
| Modular Medical, Inc. | -768 Thousand USD | 3278.516% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -339.996% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -3200.898% |
| LivaNova PLC | 771.25 Million USD | 96.835% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 545.05% |
| InMode Ltd. | 411.34 Million USD | 94.065% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -857.294% |
| Envoy Medical, Inc. | -473 Thousand USD | 5260.888% |
| Bruker Corporation | 1.51 Billion USD | 98.391% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -39918.033% |
| DexCom, Inc. | 2.28 Billion USD | 98.934% |
| Align Technology, Inc. | 2.71 Billion USD | 99.102% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -28598.566% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 76.32% |
| PAVmed Inc | -3.96 Million USD | 715.197% |
| Viveve Medical, Inc. | 620 Thousand USD | -3837.258% |
| Movano Inc. | -158 Thousand USD | 15550.0% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 77.692% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -5247.227% |
| 908 Devices Inc. | 25.32 Million USD | 3.598% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -28598.566% |
| IceCure Medical Ltd | 1.3 Million USD | -1777.769% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 93.361% |
| Venus Concept Inc. | 52.16 Million USD | 53.206% |
| Profound Medical Corp. | 4.51 Million USD | -440.782% |
| enVVeno Medical Corporation | -546 Thousand USD | 4570.879% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -79.308% |
| Orthofix Medical Inc. | 486.27 Million USD | 94.98% |
| Surmodics, Inc. | 93.05 Million USD | 73.766% |
| iCAD, Inc. | 14.53 Million USD | -67.935% |
| Nuwellis, Inc. | 4.98 Million USD | -389.886% |
| IRadimed Corporation | 50.15 Million USD | 51.332% |
| OrthoPediatrics Corp. | 111.25 Million USD | 78.058% |
| SI-BONE, Inc. | 109.42 Million USD | 77.691% |
| Semler Scientific, Inc. | 61.2 Million USD | 60.113% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 92.643% |
| Biotricity, Inc. | 8.35 Million USD | -192.128% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 470.313% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 6898.642% |
| Cytosorbents Corporation | 22.39 Million USD | -9.017% |
| Inogen, Inc. | 126.69 Million USD | 80.733% |
| MaxCyte, Inc. | 36.54 Million USD | 33.205% |
| ZimVie Inc. | 290.38 Million USD | 91.594% |
| PAVmed Inc. | -3.96 Million USD | 715.197% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Sight Sciences, Inc. | 69.17 Million USD | 64.711% |
| Insulet Corporation | 1.15 Billion USD | 97.895% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 51669.63% |
| Beyond Air, Inc. | -1.3 Million USD | 1967.712% |
| FONAR Corporation | 45.14 Million USD | 45.922% |
| AxoGen, Inc. | 127.87 Million USD | 80.91% |
| Bioventus Inc. | 328.19 Million USD | 92.562% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 87.49% |
| Inari Medical, Inc. | 434.56 Million USD | 94.383% |
| InspireMD, Inc. | 1.8 Million USD | -1250.913% |
| UFP Technologies, Inc. | 112.22 Million USD | 78.248% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -194891.613% |
| BrainsWay Ltd. | 23.09 Million USD | -5.717% |
| BIOLASE, Inc. | 16.72 Million USD | -45.964% |
| Tenon Medical, Inc. | 1.24 Million USD | -1867.043% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 30237.037% |
| CVRx, Inc. | 33.03 Million USD | 26.115% |
| AdaptHealth Corp. | 479.56 Million USD | 94.91% |
| Sintx Technologies, Inc. | 1.84 Million USD | -1224.525% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -195.14% |
| NanoVibronix, Inc. | 1.53 Million USD | -1488.224% |
| Quanterix Corporation | 70.64 Million USD | 65.446% |
| Acutus Medical, Inc. | -3.13 Million USD | 878.164% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -829.203% |
| Varex Imaging Corporation | 256.9 Million USD | 90.498% |
| Vivani Medical, Inc. | -357 Thousand USD | 6937.815% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 6112.562% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -73.62% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 53.75% |
| TransMedics Group, Inc. | 154.09 Million USD | 84.158% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -448.192% |
| NeuroMetrix, Inc. | 3.94 Million USD | -518.405% |
| Spectral AI, Inc. | 7.88 Million USD | -209.784% |
| Hyperfine, Inc. | 4.75 Million USD | -413.16% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 77.181% |
| Biomerica, Inc. | 611 Thousand USD | -3895.254% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 41.443% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 3225.788% |
| Silk Road Medical, Inc | 127.08 Million USD | 80.792% |